# Trial Phase: Syndemic Adapted Medly Uganda

Study · id `cardio:ct-nct07525271` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07525271](<https://clinicaltrials.gov/study/NCT07525271>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07525271

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT07525271. Randomized; no masking; primary purpose treatment. Start 2026-09-14 (actual); primary completion 2028-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT07525271, source copy `cardio:ctgov-nct07525271-2026-11-06`, retrieved 2026-11-18)
- Started: 2026-09-14 (actual) (ClinicalTrials.gov record NCT07525271, source copy `cardio:ctgov-nct07525271-2026-11-06`, retrieved 2026-11-18)
- Primary completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT07525271, source copy `cardio:ctgov-nct07525271-2026-11-06`, retrieved 2026-11-18)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT07525271, source copy `cardio:ctgov-nct07525271-2026-11-06`, retrieved 2026-11-18)
- Countries: Uganda (ClinicalTrials.gov record NCT07525271, source copy `cardio:ctgov-nct07525271-2026-11-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07525271-2026-11-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Trial Phase: Syndemic Adapted Medly Uganda
- Acronym: SAMU
- Condition: Mental Health
- Intervention (Device): Syndemic-Adapted Medly Uganda (SAMU)
- Lead sponsor: Yale University
- Lead sponsor class: OTHER
- Collaborator: National Institute of Mental Health (NIMH)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Yale University (`cardio:org-yale-university`)
- Registry lists this organization as a collaborator: National Institute of Mental Health (NIMH) (`cardio:org-national-institute-of-mental-health-nimh`)

## Provenance

Content hash: 342521c35e6a6149bdbebd75423c54564535d83fdd8040398deede4702087f48
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
